Ledger.Open graph →
SEC Form D · filed July 1, 2025

Arialys Therapeutics, Inc

Offering
$24.8M
Sold
$14.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Jay Lichter, Ph.D · La Jolla, CADirectorBrian Slingsby, M.D., Ph.D., M.P.H · La Jolla, CADirectorEd Hurwitz · San Diego, CADirectorDoron Kempel · New York, NYDirectorHezi Sayar · New York, NYDirectorAmit Hod · New York, NYDirectorPeter Flynn, Ph.D · San Diego, CAExec · DirectorAshish Xavier, Ph.D · San Diego, CADirectorScott Freiburger · Benton, WIDirectorChad M. Walsh · Benton, WIDirectorSandra K. Orth · Benton, WIDirectorPeter Flynn, Ph.D · San Diego, CAExec · DirectorAshish Xavier, Ph.D · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗